New molecular tools for efficient screening of cervical cancer

Disease Markers

Volumn 17, Issue 3, 2001, Pages 123-128

  Von Knebel Doeberitz, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P16INK4A; UNCLASSIFIED DRUG;

ASSAY; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; CARCINOGENESIS; DISEASE MARKER; DISTRESS SYNDROME; DYSPLASIA; EPITHELIUM CELL; GENE EXPRESSION; GENETIC RECOMBINATION; HISTOLOGY; HUMAN; ONCOGENE; PAPILLOMA VIRUS; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCIBILITY; REVIEW; SQUAMOUS EPITHELIUM; STEM CELL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION;

PAPILLOMAVIRUS;

EID: 0035663606     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/249506     Document Type: Review

References (30)

1. Estimates of the worldwide incidence of 25 major cancers in 1990
2. Estimates of the worldwide mortality from 25 cancers in 1990
3. The diagnostic value of vaginal smears in carcinoma of the uterus. 1941
4. Cervical cancer screening. Human benefits and human costs in the evaluation of screening programmes
5. Interim guidelines for management of abnormal cervical cytology
6. Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system
7. Reporting cervical intraepithelial neoplasia (CIN): Intra- and interpathologist variation and factors associated with disagreement
8. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer
9. The mildly abnormal cervical smear: Patient anxiety and choice of management
10. Cytological screening and management of abnormalities in prevention of cervical cancer: An overview with stochastic modelling
11. Papillomaviruses in human cancers
12. Monoclonality and surface lesion-specific microsatellite alterations in pre-malignant and malignant neoplasia of uterine cervix: A local field effect of genomic instability and clonal evolution
13. Natural history of cervicovaginal papillomavirus infection in young women
14. Natural history of cervical intraepithelial neoplasia: A critical review
15. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
16. The molecular genetics of cervical carcinoma
17. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
18. Withdrawing low risk women from cervical screening programmes: Mathematical modelling study
19. Evaluating cervical cancer screening programmes for developing countries
20. Benign cervical leiomyoma leading to disseminated fatal malignancy
21. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells
22. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA
23. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: Consequences for the phenotype and E6-p53 and E7-pRB interactions
24. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions
25. Overexpression of p16 INK4a as specific marker for dysplastic and neoplastic epithelial cells of the cervix Uteri
26. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm
27. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells
28. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells
29. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis
30. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes